Evidence map›Paper›PMID 29938925›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2018

Reduction of CD83 Expression on B Cells and the Genetic Basis for Rheumatoid Arthritis: Comment on the Article by Thalayasingam et al.

Yumi Tsuchida, Shuji Sumitomo, Mineto Ota, Haruka Tsuchiya, Yasuo Nagafuchi, Hirofumi Shoda, Keishi Fujio, Kazuyoshi Ishigaki, Kensuke Yamaguchi, Akari Suzuki and 2 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. CD83 Regulates the Immune Responses in Inflammatory Disorders.International journal of molecular sciences · 2023
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yumi TsuchidaGraduate School of Medicine, University of Tokyo, Tokyo, Japan.
Shuji SumitomoGraduate School of Medicine, University of Tokyo, Tokyo, Japan.ORCID 0000-0003-4980-2664
Mineto OtaGraduate School of Medicine, University of Tokyo, Tokyo, Japan.
Haruka TsuchiyaGraduate School of Medicine, University of Tokyo, Tokyo, Japan.
Yasuo NagafuchiGraduate School of Medicine, University of Tokyo, Tokyo, Japan.
Hirofumi ShodaGraduate School of Medicine, University of Tokyo, Tokyo, Japan.
Keishi FujioGraduate School of Medicine, University of Tokyo, Tokyo, Japan.
Kazuyoshi IshigakiCenter for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
Kensuke YamaguchiCenter for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
Akari SuzukiCenter for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
Yuta KochiCenter for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
Kazuhiko YamamotoCenter for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
The University of Tokyo · JPRIKEN Center for Integrative Medical Sciences · JP

Funding

Medical Research Council MR/K015346/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Arthritis, RheumatoidB-LymphocytesCD4-Positive T-LymphocytesHumans

Identifiers

PMID29938925
OpenAlexW2811509465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.